Skip to main content

Cytoskeletal messenger RNA stability in human neocortex: studies in normal aging and in Alzheimer's disease.

Lukiw WJ, Wong L, McLachlan DR

Publication: Int J Neurosci (1990) • Vol 55 • Page 81-8PMID: 2084053View on PubMed

Purpose

The purpose of this paper was to investigate the effect of post-mortem interval (PMI) and Alzheimer's disease on transcript abundance in the neocortex.

Conclusion

Postmortem degradation rates of the cytoskeletal mRNAs occurred in a transcript dependent manner. HNF-L, GFAP and alpha tubulin remained relatively stable until 4.5 h postmortem, but then declined rapidly between 4.5 and 6.5 h postmortem reaching 51%, 74%, and 78% of 0.7 h postmortem levels respectively. HNF-L, GFAP and alpha tubulin degradation continued at a slower rate after 6.5 h post-mortem declining to 36%, 60% and 72% of 0.7 h postmortem levels by 13.5 h postmortem respectively. In contrast, degradation of beta actin was robust and quick, with transcript levels 69% of 0.7 h postmortem values by 4.5 h and 34% by 13.5 h postmortem. The authors postulate that postmortem RNA stability and transcript size may be loosely correlated. Alzheimer's disease decreased the 4300 bp, but not 2600 bp HNF-L transcript abundance, but not postmortem stability. No effect of Alzheimer's disease on postmortem transcript stability was noted, but only HNF-L was directly compared.

Studies (2)

Purpose

The purpose of this study was to determine the effect of Alzheimer's disease on select transcripts.

Summary of Findings

No change in PrP27-30, 18S ribosomal RNA or the 2600 bp transcript of H1 internucleosomal marker (HNF-L) were observed by northern blot in Alzheimer's disease. A specific reduction in the 4300 bp transcript of HNF-L was associated with Alzheimer's disease. The authors conclude that while no general effect of Alzheimer's disease on transcript abundance in the neocortex was observed there is a specific decline in the 4300 bp transcript of HNF-L.
  • Biospecimens

    TissueBrain
  • Preservation Types

    Frozen
  • Diagnoses

    Alzheimer's Disease
    Autopsy
    Normal
    Multiple Sclerosis
  • Platforms

    RNADot blot or slot blot
    RNANorthern blot
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Alzheimer's disease
    Not Alzheimer's disease
    Northern blot SpecificTargeted nucleic acid
    18S ribosomal RNA
    Human neurofilament light chain (HNF-L)
    Prion protein coding for the 27-30 kDa infectious particle (PrP27-30)